These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9421685)

  • 1. Nitrosamine carcinogenesis: rodent assays, quantitative structure-activity relationships, and human risk assessment.
    Lewis DF; Brantom PG; Ioannides C; Walker R; Parke DV
    Drug Metab Rev; 1997 Nov; 29(4):1055-78. PubMed ID: 9421685
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-response study on the carcinogenicity of N-nitrosodiethanolamine in male Sprague-Dawley rats.
    Preussmann R; Habs M; Schmähl D; Eisenbrand G
    IARC Sci Publ; 1982; (41):591-6. PubMed ID: 7141565
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogenicity of methylated derivatives of N-nitrosodiethylamine and related compounds in Sprague-Dawley rats.
    Lijinsky W; Taylor HW
    J Natl Cancer Inst; 1979 Feb; 62(2):407-10. PubMed ID: 283272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of nitrosamine on in vitro cultured human esophageal epithelial cells].
    Pei XF
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):278-80. PubMed ID: 2272263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of DNA by alpha-nitrosamino aldehydes.
    Loeppky RN; Lee MP; Müller S
    IARC Sci Publ; 1994; (125):429-32. PubMed ID: 7806333
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis.
    Montesano R
    J Supramol Struct Cell Biochem; 1981; 17(3):259-73. PubMed ID: 7328674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds.
    Helguera AM; González MP; D S Cordeiro MN; Pérez MA
    Toxicol Appl Pharmacol; 2007 Jun; 221(2):189-202. PubMed ID: 17477948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of rodent carcinogenesis bioassays.
    Ward JM
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):212. PubMed ID: 18029286
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic nitrosamine ingestion in 1040 rodents: the effect of the choice of nitrosamine, the species studied, and the age of starting exposure.
    Gray R; Peto R; Brantom P; Grasso P
    Cancer Res; 1991 Dec; 51(23 Pt 2):6470-91. PubMed ID: 1933908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitrosamines].
    Jabłoński J; Moniuszko-Jakoniuk J; Sieńko D
    Med Pr; 1995; 46(1):67-74. PubMed ID: 9732850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.
    Wong HL; Murphy SE; Hecht SS
    Chem Res Toxicol; 2005 Jan; 18(1):61-9. PubMed ID: 15651850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
    Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
    Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
    Waddell WJ; Fukushima S; Williams GM
    Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: alternative approaches.
    Buist HE; Devito S; Goldbohm RA; Stierum RH; Venhorst J; Kroese ED
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):601-23. PubMed ID: 25604881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dosimetry of DNA alkylation during chronic exposure to carcinogens.
    Swenberg JA; Boucheron JA; Deal FH; Richardson FC; Tyeryar LA
    IARC Sci Publ; 1987; (84):59-63. PubMed ID: 2890580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in carcinogenesis.
    Lijinsky W
    In Vivo; 1993; 7(1):65-72. PubMed ID: 8504209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of two sequential applications of initiators in the production of hepatomas in the rat: an examination of the Solt-Farber protocol.
    Potter VR
    Cancer Res; 1984 Jun; 44(6):2733-6. PubMed ID: 6722804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.